SENSEX NIFTY

Glenmark Pharmaceuticals

Feb 25, 2015 at 13:56 | Source: CNBC-TV18
Here are a few top buzzing stocks picked by CNBC-TV18's analysts in trade today. We have - Mahindra & Mahindra, ABG Shipyard, Jubilant Foodworks, OCL India, Dalmia Bharat, Madras Fert, FACT, Dr Reddy's, Aarti Industries & Glenmark Pharma
Feb 25, 2015 at 12:12 | Source: Moneycontrol.com
Shares of Glenmark Pharma climbed over a percent intraday Wednesday on launching of oral contraceptive drug by its subsidiary in US.
Feb 25, 2015 at 09:23 | Source: Moneycontrol.com
Glenmart Generic Inc, USA, the subsidiary of Glemark Generic today announced the US market approval and introduction of AshlynaTM Extended-Cycle Oral Contraceptive Tablets, the generic equivalent of Seasonique by Teva Womans Health.
Feb 13, 2015 at 12:36 | Source: CNBC-TV18
Hitesh Mahida of Antique Stock Broking is cautious on Lupin and feels that one can buy Dr Reddys Laboratories and Glenmark Pharma.
Feb 13, 2015 at 12:21 | Source: CNBC-TV18
Hitesh Mahida of Antique Stock Broking has a positive view on Glenmark Pharma.
Feb 13, 2015 at 11:22 | Source: CNBC-TV18
Hitesh Mahida is bullish on Cipla, Glenmark and Dr Reddys Laboratories from the large cap pharma space and suggests caution on Lupin for now.
Feb 13, 2015 at 11:11 | Source: Moneycontrol.com
According to Satish Gupta of astrostocktips, pharma stocks like Lupin, Glenmark Pharma, Cipla, Sun Pharma and Dr Reddy's Labs will get astro support.
Feb 13, 2015 at 09:55 | Source: CNBC-TV18
Glenmark Pharma reported a 46.92 percent dip in its consolidated net profit at Rs 114.77 crore for the quarter ended December 31, 2014, mainly due to forex losses and increased expenses. The company had posted a profit after tax and minority interest of Rs 216.23 crore for the corresponding period of the previous fiscal.
Feb 13, 2015 at 09:02 | Source: PTI
Consolidated total income however rose to Rs 1,701.30 crore for the quarter under consideration as against Rs 1,601.75 crore for the same period year ago.
Feb 12, 2015 at 18:42 | Source: Moneycontrol.com
Glenmark Pharmaceuticals has informed that the Board of Directors of the Company at its meeting held on February 12, 2015 allotted 10,200 shares to the employees of the Company on exercise of options granted to them pursuant to ESOS 2003.
Messages on Glenmark Pharmaceuticals »

BSE/NSE Announcer

Platinum Member

6718 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has informed the Exchange regarding the press release dated July 08, 2014 titled,"Glenmark Generics receives final ANDA approval for Telmisartan Tablets."

12.41 PM Jul 8th 2014

BSE/NSE Announcer

Platinum Member

6718 Followers

Glenmark  

Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 08, 2014 titled "Glenmark Generics receives final ANDA approval for Telmisartan Tablets" Glenmark Generics Inc., USA a subsidiary of Glenmark Generics has been granted final abbreviated new drug approval (ANDA) from

12.04 PM Jul 8th 2014

phs25

Gold Member

9 Followers

Glenmark  

Glenmark Generics receives final ANDA approval for Telmisartan Tablets | 07/08/14 12:01 Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 08, 2014 titled "Glenmark Generics receives final ANDA approval for Telmisartan Tablets

12.03 PM Jul 8th 2014

BSE/NSE Announcer

Platinum Member

6718 Followers

Glenmark  

Glenmark Pharmaceuticals Ltd has informed BSE about the Shareholding Pattern as on June 30, 2014.

11.48 AM Jul 8th 2014

BSE/NSE Announcer

Platinum Member

6718 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has submitted to the Exchange a copy of press release dated July 03, 2014 titled "Glenmarks novel monoclonal antibody GBR 830 for treatment of autoimmune diseases entering human trials"

5.57 PM Jul 3rd 2014

BSE/NSE Announcer

Platinum Member

6718 Followers

Glenmark  

The Register of Members & Share Transfer Books of Glenmark Pharmaceuticals will remain closed from July 14, 2014 to July 25, 2014 (both days inclusive) for the purpose of Payment of Dividend & 36th Annual General Meeting (AGM) of the Company to be held on July 25, 2014.

7.05 PM Jun 30th 2014

adviserbola

Platinum Member

352 Followers

Marksans Pharma  

Did any body know Before promoting this venture Marksans Pharma, Mr. Mark Saldanha held the position of whole time Director at Glenmark Pharmaceuticals Ltd. Today Glenmark Pharma is trading above 570 Levels

10.32 PM Jun 11th 2014

Jayan C

New Member

6 Followers

Just Posted  

Glenmark Pharmaceuticals has opened its new monoclonal antibody manufacturing facility in La Chaux-de-Fonds, Switzerland.

6.22 PM Jun 5th 2014

Amrita Gaba

New Member

401 Followers

Glenmark  

Glenmark Pharmaceuticals S.A (GPSA), a wholly-owned subsidiary of Glenmark Pharmaceuticals Ltd. has opened its new GMP compliant monoclonal antibody manufacturing facility in La Chaux-de- Fonds, Switzerland. This manufacturing facility supplements Glenmark`s existing in-house discovery

12.57 PM Jun 5th 2014

BSE/NSE Announcer

Platinum Member

6718 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated June 04, 2014, titled"Glenmark Pharmaceuticals Inaugurates new Antibody Manufacturing Facility in La Chaux-de fonds, Switzerland".

11.11 AM Jun 4th 2014

News across the web »
Feb 05, 2015 at 19:25 | Source: FirstPost
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.